http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101703132-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7206 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-493 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-493 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate | 2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101703132-B1 |
| titleOfInvention | Markers for predicting pharmacodynamic response to imatinib and predicting method using thereof |
| abstract | The present invention relates to a marker for predicting a drug response to imatinib and a method for predicting a drug response using the same. The 12 kinds of urinary metabolites described in the present invention are used for predicting the drug response It is possible to provide an optimal treatment method for an individual, thereby providing an effective treatment environment in various aspects such as time and cost. |
| priorityDate | 2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.